SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 3c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Getty Realty (GTY) Reiterated at Market Outperform by Citizens on Investment Volumes
• Jefferies Starts Frencken Group Ltd. (FRKN:SP) at Buy
• KB Home (KBH) PT Lowered to $70 at Citizens Amid Higher Rates, Pricing Pressure